Assessment of genetically modified maize MIR162 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-025).

MLA

Mullins, Ewen, et al. “Assessment of Genetically Modified Maize MIR162 for Renewal Authorisation under Regulation (EC) No 1829/2003 (Application EFSA-GMO-RX-025).” EFSA Journal, vol. 20, no. 9, Sept. 2022, pp. 1–13. EBSCOhost, https://doi.org/10.2903/j.efsa.2022.7562.

APA

Mullins, E., Bresson, J.-L., Dalmay, T., Dewhurst, I. C., Epstein, M. M., Firbank, L. G., Guerche, P., Hejatko, J., Moreno, F. J., Naegeli, H., Nogué, F., Rostoks, N., Sánchez Serrano, J. J., Savoini, G., Veromann, E., Veronesi, F., Camargo, A. M., Goumperis, T., Kagkli, D. M., & Lenzi, P. (2022). Assessment of genetically modified maize MIR162 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-025). EFSA Journal, 20(9), 1–13. https://doi.org/10.2903/j.efsa.2022.7562

Chicago

Mullins, Ewen, Jean-Louis Bresson, Tamas Dalmay, Ian Crawford Dewhurst, Michelle M. Epstein, Leslie George Firbank, Philippe Guerche, et al. 2022. “Assessment of Genetically Modified Maize MIR162 for Renewal Authorisation under Regulation (EC) No 1829/2003 (Application EFSA-GMO-RX-025).” EFSA Journal 20 (9): 1–13. doi:10.2903/j.efsa.2022.7562.